| P2093 | author name string | Erik Ch Wolters | |
| | Johannes P J M de Munter | |
| P2860 | cites work | Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 |
| | Brain endothelial cell-cell junctions: how to "open" the blood brain barrier | Q24654117 |
| | A sensitive and reliable locomotor rating scale for open field testing in rats | Q29619624 |
| | Mesenchymal stem cells as trophic mediators | Q29619806 |
| | Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 |
| | Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. | Q33237964 |
| | Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial | Q33282978 |
| | Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb | Q33310549 |
| | Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data | Q33547640 |
| | Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 |
| | Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor | Q34123733 |
| | Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century | Q35172345 |
| | Mesenchymal stem cells and their potential as cardiac therapeutics | Q35830869 |
| | Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. | Q36132019 |
| | Clinical interpretation and use of stroke scales | Q36510221 |
| | Neuronal repair and replacement in spinal cord injury | Q36849282 |
| | Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats | Q36888097 |
| | Human stem cells for CNS repair. | Q36954408 |
| | Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord | Q37020073 |
| | Advances in the management of spinal cord injury. | Q37722134 |
| | Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications | Q37898082 |
| | Review of current and emerging therapies in acute ischemic stroke | Q37945127 |
| | Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention | Q37963655 |
| | Trends in life expectancy after spinal cord injury | Q38467095 |
| | Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor | Q40504543 |
| | Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. | Q41522029 |
| | Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke | Q42263708 |
| | Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study | Q42731842 |
| | The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury. | Q43143048 |
| | Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. | Q44487129 |
| | A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats | Q44829964 |
| | Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children | Q45135454 |
| | Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up | Q45840337 |
| | Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice | Q47236018 |
| | Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. | Q47331040 |
| | Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF. | Q47842605 |
| | Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats | Q48004173 |
| | Cerebrospinal fluid following cerebral ischemia accelerates the proliferation of bone marrow stromal cells in vitro | Q48363862 |
| | Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection | Q48425513 |
| | Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats | Q48426738 |
| | Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages | Q48569546 |
| | Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials | Q48671367 |
| | Spatial memory disturbance after focal cerebral ischemia in rats | Q48936613 |
| | Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats | Q48951431 |
| | Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique | Q48959402 |
| | Intravenous autologous bone marrow mononuclear cells for ischemic stroke | Q49015926 |
| | GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury | Q50455837 |
| | Late neurologic recovery after traumatic spinal cord injury. | Q50751346 |
| | A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway. | Q51137644 |
| | Regenerative medicine for neurological disorders. | Q51143014 |
| | Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. | Q53163674 |
| | Functional outcome of bone marrow stem cells (CD45(+)/CD34(-)) after cell therapy in chronic spinal cord injury in Wistar rats. | Q53479505 |
| | Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients | Q57681186 |
| | A Simple and Reproducible Model of Spinal Cord Injury Induced by Epidural Balloon Inflation in the Rat | Q59549288 |
| | Mortality after traumatic spinal cord injury: 50 years of follow-up | Q60696658 |
| | Intra-Arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Patients with Moderate to Severe Middle Cerebral Artery Acute Ischemic Stroke | Q62109410 |
| | Spinal cord injuries in Iceland 1973-1989. A follow up study | Q70593303 |
| | CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury | Q73503153 |
| | Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) | Q78007776 |
| | Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury | Q79705120 |
| | Neurological and functional recovery in human stroke are associated with peripheral blood CD34+ cell mobilization | Q79898170 |
| | Neuroprotective effect of bone marrow-derived mononuclear cells promoting functional recovery from spinal cord injury | Q80546117 |
| | Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke | Q82980062 |
| | Differentiation of human bone marrow mesenchymal stem cells into neuron-like cells in vitro | Q83306674 |
| | A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury | Q84127862 |
| | Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts | Q84313630 |
| P433 | issue | 1 | |
| P304 | page(s) | 91-102 | |
| P577 | publication date | 2012-07-29 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | 70th Birthday symposium of Prof. Dr. Riederer: autologous adult stem cells in ischemic and traumatic CNS disorders | |
| P478 | volume | 120 | |